Cypherpunk Technologies, Inc. (CYPH)
1.67
-0.04
(-2.34%)
USD |
NASDAQ |
Sep 02, 16:00
1.67
0.00 (0.00%)
After-Hours: 19:39
Cypherpunk Technologies Enterprise Value : 176.69M for Sept. 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 01, 2026 | 176.69M |
| August 31, 2026 | 189.08M |
| August 28, 2026 | 176.69M |
| August 27, 2026 | 196.09M |
| August 26, 2026 | 168.07M |
| August 25, 2026 | 169.15M |
| August 24, 2026 | 173.46M |
| August 21, 2026 | 145.44M |
| August 20, 2026 | 120.65M |
| August 19, 2026 | 107.72M |
| August 18, 2026 | 79.21M |
| August 17, 2026 | 68.42M |
| August 14, 2026 | 61.81M |
| August 13, 2026 | 62.25M |
| August 12, 2026 | 63.31M |
| August 11, 2026 | 65.69M |
| August 10, 2026 | 65.66M |
| August 07, 2026 | 66.62M |
| August 06, 2026 | 65.03M |
| August 05, 2026 | 71.41M |
| August 04, 2026 | 66.77M |
| August 03, 2026 | 61.04M |
| July 31, 2026 | 56.06M |
| July 30, 2026 | 59.83M |
| July 29, 2026 | 57.17M |
| Date | Value |
|---|---|
| July 28, 2026 | 58.59M |
| July 27, 2026 | 59.96M |
| July 24, 2026 | 59.39M |
| July 23, 2026 | 63.65M |
| July 22, 2026 | 64.85M |
| July 21, 2026 | 72.05M |
| July 20, 2026 | 69.67M |
| July 17, 2026 | 68.72M |
| July 16, 2026 | 69.20M |
| July 15, 2026 | 73.51M |
| July 14, 2026 | 71.28M |
| July 13, 2026 | 67.71M |
| July 10, 2026 | 68.16M |
| July 09, 2026 | 67.85M |
| July 08, 2026 | 62.57M |
| July 07, 2026 | 67.85M |
| July 06, 2026 | 65.16M |
| July 02, 2026 | 64.19M |
| July 01, 2026 | 61.83M |
| June 30, 2026 | 58.40M |
| June 29, 2026 | 52.99M |
| June 26, 2026 | 51.44M |
| June 25, 2026 | 49.56M |
| June 24, 2026 | 50.65M |
| June 23, 2026 | 54.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Indaptus Therapeutics, Inc. | 139.01M |
| ACADIA Pharmaceuticals, Inc. | 4.090B |
| Alnylam Pharmaceuticals, Inc. | 32.59B |
| Anika Therapeutics, Inc. | 269.35M |
| Savara, Inc. | 956.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 39.39M |
| Total Expenses (Quarterly) | -39.39M |
| EPS Diluted (Quarterly) | 0.1812 |
| Earnings Yield | 33.87% |
| Normalized Earnings Yield | -4.174 |